Introduction
Total ankle arthroplasty (TAA) have been performed in selected patients with end-stage ankle disorders caused by osteoarthritis for over 40 years 1 . Original implant designs were associated with subsidence and loosening, and failure rates for patients needing reoperation or revision were as high as 8.3-50% over the 5-to 12.5-year follow-up 1 . These failure rates have proposed considerable concern about the long-term results of these prostheses. TAA designs were subsequently developed on the support of several studies of normal ankle biomechanics and a review of earlier implant failures [2] [3] [4] . The present implant designs are either two or three components, with either fixed or mobile bearings, and cementless-type fixation is considered superior by most implant manufacturers and authors 2, [4] [5] [6] [7] [8] . In addition, TAA is considered by some to be a reasonable alternative to ankle arthrodesis 9, 10 . Most implants for TAA consist of metallic components [11] [12] [13] . One of these implant designs-HINTEGRA 
. The HINTEGRA ® prostheses were implanted in a patient in Thailand in 2013. Other implants such as FINE prostheses (Nakashima Medical, Okayama, Japan), which consists of metal tibial and talar components Introduction There are few reports for total ankle arthroplasty (TAA) with ceramic implant. We performed a systematic search for relevant articles published in English and other languages between January 1990 and February 2012. We aimed to report the cumulative medium-term outcomes (survivorship/failure rates) for patients treated with ceramic TAA in patients with end-stage arthritis.
Materials and methods
Qualified studies were evaluated using the Coleman methodology score, and data collection was independently implemented by three reviewers.
Results
Four studies qualified for analysis, describing 138 implants (125 TNK, 13 ND-Bioceram). Only one study provided survivorship analysis data as 77% at 14.1 years. The pooled failure rate was 6.3% (95% confidence interval: 6.2-7.1) over a mean follow-up of 5.6 years. Ceramic TAA prostheses currently used in patients with end-stage arthritis achieved satisfactory medium-term outcomes compared with previous non-ceramic TAA studies with a closed length of mean follow-up.
Conclusion
The study showed that the use of ceramic TAA prosthesis had a failure rate of 6.3%, which is a satisfactory result. We call for further studies regarding comparisons between . However, some studies have reported the results of other type of TAA prosthesis as the ceramic component. Since the 1980s, the TAA system with alumina ceramic component has been developed 1 . The ND-Bioceram was an earlier version that was implanted in Japan. In 1991, the ankle system such as the TNK implant (KYOCERA Medical Corporation, Osaka, Japan) was developed, which consisted of a beaded coating of alumina ceramics on the surface of the tibial and talar components to enhance the affinity between the bone and prosthesis, with polyethylene on a tibial-bearing surface (Figure 3 ) 1, 21, 22 . In the main fixation, a screw was generally used to link the tibial component and bone rather than cement ( Figure 4) 22 . Yamaguchi et al. 23 measured in vivo kinematics of these prostheses (two-component TAA) and assessed the congruency of the articular surface during the stance phase of gait. They found that the range of sagittal rotation was maintained during the stance phase of gait after this TAA implantation; however, the axial and coronal rotations were less than those of the natural ankle 23 . Incongruency of the articular surface occurred in 40% of the patients 23 .
There is currently no evidencebased systematic review evaluating the outcomes and failure rates of the ceramic TAA system. We therefore systematically reviewed the literature to determine the outcomes of this TAA system and to provide evidence-based cumulative data of the clinical failure rate, survivorship and the functional outcomes in patients who were implanted with the ceramic TAA.
Materials and methods

Study selection
Typical systematic review guidelines were used. Initially, a prospective protocol was written to define purposes, search criteria, study selection criteria, elements of interest and plans for analysis.
According to the protocol, a comprehensive search of the literature was performed for studies between January 1990 and February 2012 using the MEDLINE ® , Cochrane, EMBASE™ and CINAHL® databases and the following search terms:
'total', 'ankle' and 'arthroplasty' or 'replacement'.
These electronic searches were supplemented by searching the reference sections of several papers to authenticate the inclusion of all related papers and current reviews. Search results were screened independently by three reviewers (CA, SC and AK) and determined as relevant, irrelevant or Competing interests: none declared. Conflict of interests: none declared.
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uncertain according to study eligibility criteria. Conflicts regarding study inclusion were resolved by consensus discussions or the decision of the senior author (CA). This study was approved by the ethical committee of the authors' institution.
Inclusion and exclusion criteria
To satisfy inclusion criteria, the study must have (1) reported the outcomes, failure rates and indications or reasons for TAA; (2) included at least 20 ankle joints in the whole study; (3) had a mean follow-up of at least 2 years and (4) the use of ceramic TAA. Studies were excluded if (1) the study used old prosthesis designs implanted before the early 1980s; (2) the ankle arthrodesis or arthroplasty failed or (3) several publications on the same patient population were pooled. All study designs were eligible, including randomized controlled trials, prospective and retrospective non-randomized controlled trials and case series, according to the Journal of Bone and Joint Surgery criteria level I-IV 24 . The methods used in these studies were assessed by a modified Coleman methodology score (CMS) (Table 1) 25 , with scores ranging from 0 to 100, where 100 indicated that the study had a perfect design and largely empty of chance, several forms of bias or confounding factors.
Data collection and statistical methods
Patient demographics, number of cases, mean follow-up, functional outcome scales and scores, failure rates, causes of failures and rates of prosthesis survivorship were recorded. TAA failure was defined as the necessity to change or remove prosthesis components, convert the TAA to an ankle arthrodesis or TAA-related amputation. The employed studies were reviewed by three orthopaedic surgeons (CA, SC and AK). Protocol-defined data from each eligible study were collected 30 and authors' score 1 were used to assess ankle function after TAA (Table 5) . In most studies, ankle scores improved after TAA; one study did not include a preoperative score to compare with the postoperative score 27 , and therefore, improvement could not be discerned (Table 5 ).
All studies evaluated TAA using radiography 1, 22, 27, 28 . Most studies evaluated the presence of radiolucency and prosthesis loosening or subsidence (Table 4) , with variation in methods used and in definitions of component loosening or subsidence. The pooled percentage for radiolucency was 54.8% (95% CI: 47.4-59.9) and that for loosening or subsidence was 21.5% (95% CI: 19.1-24.9). Values set by consensus among the three reviewers (CA, SC and AK) or the decision of the senior author (CA).
and confirmed by the same three authors. Differences were resolved by consensus discussions or the decision of the senior author (CA) prior to data entry. The rates of survivorship and failure were calculated using a meta-analysis by pooling group results across studies 26 . Data are shown as median and range or mean and 95% confidence interval (CI). All statistical analyses were performed with Microsoft Excel 2010 (Microsoft Corp., Redmond, WA, USA).
Results
We identified four studies 1, 22, 27, 28 published from January 1990 to February 2012 that reported the findings of 138 TAAs (125 TNK, 13 ND-Bioceram). Only one of the four articles compared the outcomes of TAA (20 cases) with ankle arthrodesis (17 cases) 28 . There were no randomized trials. In two of the studies, the patient recruitment rate was greater than 90% 1, 22 . The results of the modified CMS for each study are summarized in Table 2 , and demographic data are shown in Table  3 . The indications for TAA varied among different studies (Table 3) . Rheumatoid arthritis was the most common cause (71.7%) of arthritis in ankles undergoing ceramic TAA (Table 3 ).
Discussion
The current study reports the evidence-based cumulative data of clinical failure rates, survivorship and the functional outcomes of ceramic TAA. From four eligible studies, we found only one comparative study between ceramic TAA and ankle arthrodesis that favoured ceramic TAA in terms of postoperative score 28 . Most studies reported that ankle scores were improved after TAA. However, the functional outcomes for patients treated with ceramic TAA were difficult to determine because of the varied scoring methods used in each study such as AOFAS-Hindfoot score 29 , Evanski and Waugh score 30 and Japanese Orthopaedic Association score 31 . One group had created their own scoring system 1 . Consequently, there may be an increased bias caused by the heterogeneity of outcome measures, such that, at this point, it is difficult to compare the different outcomes of ceramic TAA and other designs of TAA studies in this systematic review.
Of the four studies, only one study reported that the pooled mean survival rate of TAA was 77% at 14.1 years 27 ; these results might have been acceptable if these numbers had been compared with those reported in previous studies 9, 25, 32 . TAA survivorship data therefore should Licensee Competing interests: none declared. Conflict of interests: none declared.
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All authors abide by the Association for Medical Ethics (AME) ethical rules of disclosure. be interpreted with caution. Overall, TAA failure rate was only 6.3% (ranging from 4.3% to 11.1% between centres), with a mean followup time of 5.6 years. This failure rate was lower than that in previous non-ceramic TAA studies that were mostly conducted with closed lengths of follow-up 9, 32 . The most common causes for TAA implant failure in our review were aseptic loosening and infection, which were quite similar with findings reported in previous studies 9, 32 .
For the radiographic outcomes, the pooled percentages of radiolucency and loosening or subsidence were a bit higher than outcomes using similar measures outlined in a previous review 25 ; this review had predominantly collected studies from metallic implants with the closed length of follow-up as those in the present study. However, it may be difficult to conclude anything meaningful in terms of the differences of radiographic outcomes between ceramic and non-ceramic studies because radiolucency and prosthesis loosening or subsidence were determined by different methods using disparate definitions of what constituted component loosening or subsidence. We found several limitations in the literature reviewed. (1) The heterogeneity in study design and outcome measurement did not allow for direct conclusions to be made from many of the ceramic TAA data. (2) Only one study reported the pooled mean survival rate of TAA 27 . (3) Some outcome scores including AOFAS-Hindfoot score were not well validated 29, 33 , whereas some researchers developed their own outcome scales 1 . These may lend to biased conclusions in the studies. (4) The definitions of the radiographic outcome measures were different between studies. (5) Finally, we assessed the quality of the studies using the CMS 25 . To improve the reliability of the CMS findings, the assessment was performed by three independent reviewers, and a consensus was reached or a decision was made by the senior author (CA), although a formal validation was not achieved. The total score out of a possible 100 points was employed to obtain a comprehension of the study quality 25 . The mean CMS score in our study was 39.8 points, which was quite low compared with that in a previous review study (70.6) 32 . This may represent the inferior quality of overall ceramic TAA studies. Because of these limitations, it was not possible to reliably report the pooled history of ceramic TAA implants or indirectly compare the results of ceramic TAA with previous nonceramic TAA studies 9, 32 . In addition, we found only one comparative study between ceramic TAA and ankle arthrodesis 28 . More future trials comparing ceramic TAA with the use of arthrodesis are needed to provide a more clinically relevant assessment of the benefit and role of ceramic TAA in patients with end-stage arthritis.
However, based on identical definitions of implant failure and failure causes among the eligible studies in our review and previous studies 9, 32 , our review showed some worthwhile information, including useful estimates of failure rates, causes and prognoses, such as the pooled failure rate, which was lower than that in previous non-ceramic TAA studies with closed length mean follow-up time 9, 32 . This result demonstrated that ceramic TAA has an acceptable rate of implant failure. Collectively, the results of this review may help to indicate the clinical utility of ceramic TAA in patients with end-stage arthritis.
Conclusion
The present study showed that currently used ceramic TAA prostheses achieved satisfactory results in terms of failure rate (6.3%) across the med ium-term follow-up of 5.6 years. This finding includes the results of only one comparative study that favoured the use of ceramic TAA. Pooled failure rate was lower than that previously reported in studies that mainly comprised non-ceramic TAAs with a closed length of mean follow-up. Comparative studies between ceramic TAA and ankle arthrodesis are lacking, and further studies are necessary to determine the medium-to long-term advantages of ceramic TAA compared with ankle arthrodesis in patients with end-stage arthritis.
